Kinin B1- and B2-Receptor Subtypes Contract Isolated Bovine Ciliary Muscle: Their Role in Ocular Lens Function and Intraocular Pressure Reduction.

IF 4.3 3区 医学 Q2 CHEMISTRY, MEDICINAL
Pharmaceuticals Pub Date : 2024-11-08 DOI:10.3390/ph17111501
Najam A Sharif, Madura Kulkarni-Chitnis, Anthonia Okolie, Ya Fatou Njie-Mbye, Sunny E Ohia
{"title":"Kinin B1- and B2-Receptor Subtypes Contract Isolated Bovine Ciliary Muscle: Their Role in Ocular Lens Function and Intraocular Pressure Reduction.","authors":"Najam A Sharif, Madura Kulkarni-Chitnis, Anthonia Okolie, Ya Fatou Njie-Mbye, Sunny E Ohia","doi":"10.3390/ph17111501","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Bradykinin is an endogenously produced nonapeptide with many physiological and pathological functions that are mediated by two pharmacologically defined receptor subtypes, B1- and B2-receptors. Current studies sought to characterize the functional bradykinin (BK) receptors present in freshly isolated bovine ciliary muscle (BCM) using an organ-bath tissue contraction system. <b>Methods:</b> Cumulative longitudinal isometric tension responses of BCM strips (4-5 mm) were recorded before and after the addition of test compounds to BCM strips hooked up to an isometric strain gauge transducer system. <b>Results:</b> BK and its analogs (7-11 concentrations) contracted BCM in a biphasic concentration-dependent manner. The first high affinity/potency phase accounted for 40-60% of the maximal contraction by each of BK (potency, EC<sub>50</sub> = 0.9 ± 0.3 nM), Lys-BK (EC<sub>50</sub> = 0.7 ± 0.1 nM), Met-Lys-BK (EC<sub>50</sub> = 1 ± 0.1 nM), Hyp3-BK (EC<sub>50</sub> = 1 ± 0.2 nM), RMP-7 (EC<sub>50</sub> = 3.5 ± 0.5 nM), and Des-Arg<sup>9</sup>-BK (EC<sub>50</sub> = 10 ± 0.4nM) (mean ± SEM, n = 3-8). The second lower activity phase of contraction potency values for these peptides ranged between 100 nM and 3 µM. In the presence of a selective B1-receptor antagonist (R715; 0.1-10 µM), the concentration-response curves to Des-Arg9-BK (B1-receptor agonist) were still observed, indicating activation of B2-receptors by this kinin. Likewise, when B2-receptors were completely blocked by using a B2-selective antagonist (WIN-64338; 1-10 µM), BK still induced BCM contraction, now by stimulating B1-receptors. <b>Conclusions:</b> This agonist/antagonist profile of BCM receptors indicated the presence of both B1- and B2-receptor subtypes, both being responsible for contracting this smooth muscle. The BCM kinin receptors may be involved in changing the shape of the ocular lens to influence accommodation, and since the ciliary muscle is attached to the trabecular meshwork through which aqueous humor drains, endogenously released kinins may regulate intraocular pressure.</p>","PeriodicalId":20198,"journal":{"name":"Pharmaceuticals","volume":"17 11","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/ph17111501","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Bradykinin is an endogenously produced nonapeptide with many physiological and pathological functions that are mediated by two pharmacologically defined receptor subtypes, B1- and B2-receptors. Current studies sought to characterize the functional bradykinin (BK) receptors present in freshly isolated bovine ciliary muscle (BCM) using an organ-bath tissue contraction system. Methods: Cumulative longitudinal isometric tension responses of BCM strips (4-5 mm) were recorded before and after the addition of test compounds to BCM strips hooked up to an isometric strain gauge transducer system. Results: BK and its analogs (7-11 concentrations) contracted BCM in a biphasic concentration-dependent manner. The first high affinity/potency phase accounted for 40-60% of the maximal contraction by each of BK (potency, EC50 = 0.9 ± 0.3 nM), Lys-BK (EC50 = 0.7 ± 0.1 nM), Met-Lys-BK (EC50 = 1 ± 0.1 nM), Hyp3-BK (EC50 = 1 ± 0.2 nM), RMP-7 (EC50 = 3.5 ± 0.5 nM), and Des-Arg9-BK (EC50 = 10 ± 0.4nM) (mean ± SEM, n = 3-8). The second lower activity phase of contraction potency values for these peptides ranged between 100 nM and 3 µM. In the presence of a selective B1-receptor antagonist (R715; 0.1-10 µM), the concentration-response curves to Des-Arg9-BK (B1-receptor agonist) were still observed, indicating activation of B2-receptors by this kinin. Likewise, when B2-receptors were completely blocked by using a B2-selective antagonist (WIN-64338; 1-10 µM), BK still induced BCM contraction, now by stimulating B1-receptors. Conclusions: This agonist/antagonist profile of BCM receptors indicated the presence of both B1- and B2-receptor subtypes, both being responsible for contracting this smooth muscle. The BCM kinin receptors may be involved in changing the shape of the ocular lens to influence accommodation, and since the ciliary muscle is attached to the trabecular meshwork through which aqueous humor drains, endogenously released kinins may regulate intraocular pressure.

激肽 B1 和 B2 受体亚型收缩离体牛睫状肌:它们在眼球晶状体功能和降低眼压中的作用
背景:缓激肽是一种内源性产生的非肽类物质,具有多种生理和病理功能,由两种药理学定义的受体亚型(B1-和B2-受体)介导。目前的研究试图利用器官-水浴组织收缩系统确定新鲜分离的牛睫状肌(BCM)中存在的缓激肽(BK)功能受体的特征。方法:在牛睫状肌条(4-5 毫米)上添加测试化合物前后,记录牛睫状肌条的累积纵向等长张力反应,并将其连接到等长应变片传感器系统上。结果显示BK 及其类似物(7-11 个浓度)以双相浓度依赖的方式收缩 BCM。第一个高亲和力/效力阶段占 BK(效力,EC50 = 0.9 ± 0.3 nM)、Lys-BK(EC50 = 0.7 ± 0.1 nM)、Met-Lys-BK(EC50 = 1 ± 0.1 nM)、Hyp3-BK(EC50 = 1 ± 0.2 nM)、RMP-7(EC50 = 3.5 ± 0.5 nM)和 Des-Arg9-BK (EC50 = 10 ± 0.4nM)(平均值 ± SEM,n = 3-8)。这些肽的第二低活性阶段收缩效力值介于 100 nM 和 3 µM 之间。在存在选择性 B1 受体拮抗剂(R715;0.1-10 µM)的情况下,仍能观察到 Des-Arg9-BK(B1 受体激动剂)的浓度反应曲线,这表明激肽激活了 B2 受体。同样,当使用 B2 选择性拮抗剂(WIN-64338;1-10 µM)完全阻断 B2 受体时,BK 仍能诱导 BCM 收缩,现在是通过刺激 B1 受体。结论BCM 受体的这种激动剂/拮抗剂特征表明存在 B1 和 B2 受体亚型,两者都负责收缩这种平滑肌。睫状肌激肽受体可能参与改变眼球晶状体的形状以影响调节,由于睫状肌与小梁网相连,房水通过小梁网排出,内源性释放的激肽可能调节眼压。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmaceuticals
Pharmaceuticals Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
6.10
自引率
4.30%
发文量
1332
审稿时长
6 weeks
期刊介绍: Pharmaceuticals (ISSN 1424-8247) is an international scientific journal of medicinal chemistry and related drug sciences.Our aim is to publish updated reviews as well as research articles with comprehensive theoretical and experimental details. Short communications are also accepted; therefore, there is no restriction on the maximum length of the papers.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信